# FDA Inspection 1219763 - Nisshin Pharma Inc. - September 08, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/nisshin-pharma-inc/3273b822-6ecc-430c-b066-ae0c649f9dbf
Source feed: FDA_Inspections

> FDA Inspection 1219763 for Nisshin Pharma Inc. on September 08, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219763
- Company Name: Nisshin Pharma Inc.
- Inspection Date: 2023-09-08
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 911588 - 2014-12-18](https://www.globalkeysolutions.net/records/fda_inspections/nisshin-pharma-inc/da02bc8c-c787-4b69-81b8-5452c0b374a8)
- [FDA Inspection 778162 - 2012-04-12](https://www.globalkeysolutions.net/records/fda_inspections/nisshin-pharma-inc/c73d0473-f50a-45f5-9255-f1f98eab99e0)

Company: https://www.globalkeysolutions.net/companies/nisshin-pharma-inc/5ac9c35f-07d2-4765-a496-d5f526b301fe

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c